Sirtuins are considered an emerging therapeutical target in sarcopenia, and the circumstance that resveratrol is a strong activator of SIRT1 has boosted research on the putative anti-sarcopenic action of resveratrol [207]. This evidence concerns the gene SIRT1 and sarcopenia.